Skip to content

WIMEQ: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

WIMEQ

BE 0859.624.094
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2023 against 2024filed annual accounts (NBB)
Net result for the year
€2,243
2023 · -€2,184+€4,427
Equity
€41,454
2023 · €39,210+€2,243
Cash
€32,619
2023 · €28,014+€4,605
Balance sheet total
€43,705
2023 · €41,749+€1,956

Largest movements

2023 to 2024
Assets
  • Cash +€4,605

    up €4,605 (+16.4%), from €28,014 to €32,619

    mainly Net result for the year (+€2,243) and Receivables within one year (+€1,515)

  • Receivables within one year -€1,515

    down €1,515 (-16.9%), from €8,946 to €7,431

    of which Trade receivables: -€2,058

  • Stocks and contracts -€1,156

    down €1,156 (-25.0%), from €4,625 to €3,469

Equity and liabilities
  • Reserves +€2,243

    up €2,243 (+25.0%), from €8,979 to €11,222

    of which Distributable reserves: +€2,243

  • Advances received -€1,025

    no longer reported in 2024 (was €1,025)

  • Tax, wage and social debts +€795

    up €795 (+737.3%), from €108 to €903

Income statement
  • Gross operating margin +€4,941

    up €4,941, from -€1,395 to €3,546

  • Taxes +€813

    up €813 (+851.7%), from €95 to €909

  • Depreciation -€248

    no longer reported in 2024 (was €248)

  • Financial income +€57

    up €57 (+124.1%), from €46 to €102

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 -€2,184
Gross operating margin +€4,941
Depreciation +€248
Other operating charges -€3
Financial income +€57
Financial charges -€2
Taxes -€813
Result 2024 €2,243

Cash bridge derived

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€4,605
Investment €0
Financing €0
Cash 2023 €28,014
Net result for the year +€2,243
Stocks and contracts +€1,156
Receivables within one year +€1,515
Deferred charges and accrued income -€22
Trade debts -€57
Tax, wage and social debts +€795
Advances received -€1,025
Cash 2024 €32,619
Every line side by side 37 lines
Line Code 2023 2024 Change %
Total assets 20/58 €41,749 €43,705 +€1,956 +4.7%
Current assets 29/58 €41,749 €43,705 +€1,956 +4.7%
Stocks and contracts in progress 3 €4,625 €3,469 -€1,156 -25.0%
Stocks 30/36 €4,625 €3,469 -€1,156 -25.0%
Amounts receivable within one year 40/41 €8,946 €7,431 -€1,515 -16.9%
Trade receivables 40 €3,368 €1,310 -€2,058 -61.1%
Other amounts receivable 41 €5,578 €6,122 +€543 +9.7%
Cash at bank and in hand 54/58 €28,014 €32,619 +€4,605 +16.4%
Deferred charges and accrued income 490/1 €164 €186 +€22 +13.3%
Total equity and liabilities 10/49 €41,749 €43,705 +€1,956 +4.7%
Equity 10/15 €39,210 €41,454 +€2,243 +5.7%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €8,979 €11,222 +€2,243 +25.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €7,119 €9,362 +€2,243 +31.5%
Profit (loss) carried forward 14 €11,632 €11,632 = 0.0%
Amounts payable 17/49 €2,539 €2,252 -€287 -11.3%
Amounts payable within one year 42/48 €2,539 €2,252 -€287 -11.3%
Trade debts 44 €540 €483 -€57 -10.6%
Suppliers 440/4 €540 €483 -€57 -10.6%
Advances received on contracts in progress 46 €1,025 - -€1,025
Taxes, remuneration and social security 45 €108 €903 +€795 +737.3%
Taxes 450/3 €108 €903 +€795 +737.3%
Other amounts payable 47/48 €866 €866 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €248 - -€248
Other operating charges 640/8 €446 €449 +€3 +0.6%
Gross operating margin 9900 -€1,395 €3,546 +€4,941
Operating profit (loss) 9901 -€2,089 €3,096 +€5,186
Financial income 75/76B €46 €102 +€57 +124.1%
Recurring financial income 75 €46 €102 +€57 +124.1%
Financial charges 65/66B €45 €47 +€2 +3.8%
Recurring financial charges 65 €45 €47 +€2 +3.8%
Profit (loss) for the period before taxes 9903 -€2,089 €3,152 +€5,241
Income taxes 67/77 €95 €909 +€813 +851.7%
Profit (loss) for the period 9904 -€2,184 €2,243 +€4,427
Profit (loss) for the period to be appropriated 9905 -€2,184 €2,243 +€4,427

Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.